Fluorine in PDB 8un4: Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
Enzymatic activity of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
All present enzymatic activity of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One):
3.6.5.2;
Protein crystallography data
The structure of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One), PDB code: 8un4
was solved by
M.H.Ultsch,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.74 /
1.57
|
Space group
|
P 21 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
40.73,
55.69,
85.49,
90,
90,
90
|
R / Rfree (%)
|
19 /
21.5
|
Other elements in 8un4:
The structure of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
(pdb code 8un4). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One), PDB code: 8un4:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 8un4
Go back to
Fluorine Binding Sites List in 8un4
Fluorine binding site 1 out
of 4 in the Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F203
b:22.6
occ:1.00
|
F
|
A:XV3203
|
0.0
|
22.6
|
1.0
|
C6
|
A:XV3203
|
1.3
|
22.9
|
1.0
|
F2
|
A:XV3203
|
2.1
|
21.1
|
1.0
|
F1
|
A:XV3203
|
2.1
|
21.7
|
1.0
|
C5
|
A:XV3203
|
2.4
|
21.3
|
1.0
|
H1
|
A:XV3203
|
2.5
|
26.9
|
1.0
|
C1
|
A:XV3203
|
3.1
|
20.3
|
1.0
|
C
|
A:XV3203
|
3.2
|
22.2
|
1.0
|
CB
|
A:GLN99
|
3.4
|
26.1
|
1.0
|
C4
|
A:XV3203
|
3.4
|
21.1
|
1.0
|
O
|
A:TYR96
|
3.5
|
21.4
|
1.0
|
F3
|
A:XV3203
|
3.6
|
24.8
|
1.0
|
H3
|
A:XV3203
|
3.6
|
26.9
|
1.0
|
CG1
|
A:ILE100
|
3.7
|
21.3
|
1.0
|
CD1
|
A:TYR96
|
3.7
|
19.2
|
1.0
|
C7
|
A:XV3203
|
3.8
|
21.4
|
1.0
|
CA
|
A:TYR96
|
3.9
|
19.0
|
1.0
|
C12
|
A:XV3203
|
4.0
|
23.5
|
1.0
|
H2
|
A:XV3203
|
4.1
|
26.9
|
1.0
|
C
|
A:TYR96
|
4.2
|
25.9
|
1.0
|
N
|
A:ILE100
|
4.2
|
23.4
|
1.0
|
CB
|
A:TYR96
|
4.2
|
18.5
|
1.0
|
CD1
|
A:ILE100
|
4.3
|
20.5
|
1.0
|
CG
|
A:GLN99
|
4.4
|
22.0
|
1.0
|
C2
|
A:XV3203
|
4.4
|
21.3
|
1.0
|
CG
|
A:TYR96
|
4.4
|
22.8
|
1.0
|
C
|
A:GLN99
|
4.5
|
25.1
|
1.0
|
CA
|
A:GLN99
|
4.5
|
23.1
|
1.0
|
CG1
|
A:VAL9
|
4.5
|
19.4
|
1.0
|
CE1
|
A:TYR96
|
4.6
|
21.0
|
1.0
|
N
|
A:XV3203
|
4.6
|
22.6
|
1.0
|
CB
|
A:VAL9
|
4.7
|
15.5
|
1.0
|
C8
|
A:XV3203
|
4.8
|
20.4
|
1.0
|
CA
|
A:ILE100
|
4.8
|
23.9
|
1.0
|
CB
|
A:ILE100
|
4.8
|
20.8
|
1.0
|
CG2
|
A:VAL9
|
4.8
|
17.9
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 8un4
Go back to
Fluorine Binding Sites List in 8un4
Fluorine binding site 2 out
of 4 in the Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F203
b:21.7
occ:1.00
|
F1
|
A:XV3203
|
0.0
|
21.7
|
1.0
|
C6
|
A:XV3203
|
1.3
|
22.9
|
1.0
|
F2
|
A:XV3203
|
2.1
|
21.1
|
1.0
|
F
|
A:XV3203
|
2.1
|
22.6
|
1.0
|
C5
|
A:XV3203
|
2.4
|
21.3
|
1.0
|
C7
|
A:XV3203
|
2.7
|
21.4
|
1.0
|
C4
|
A:XV3203
|
2.9
|
21.1
|
1.0
|
C8
|
A:XV3203
|
3.1
|
20.4
|
1.0
|
C12
|
A:XV3203
|
3.3
|
23.5
|
1.0
|
CG1
|
A:VAL9
|
3.3
|
19.4
|
1.0
|
CD1
|
A:TYR96
|
3.5
|
19.2
|
1.0
|
CL
|
A:XV3203
|
3.5
|
21.4
|
1.0
|
CB
|
A:VAL9
|
3.7
|
15.5
|
1.0
|
C1
|
A:XV3203
|
3.7
|
20.3
|
1.0
|
F3
|
A:XV3203
|
3.7
|
24.8
|
1.0
|
CE1
|
A:TYR96
|
3.9
|
21.0
|
1.0
|
C9
|
A:XV3203
|
4.0
|
19.6
|
1.0
|
H1
|
A:XV3203
|
4.1
|
26.9
|
1.0
|
C11
|
A:XV3203
|
4.2
|
22.8
|
1.0
|
N
|
A:XV3203
|
4.2
|
22.6
|
1.0
|
CE
|
A:MET72
|
4.3
|
21.5
|
1.0
|
C
|
A:XV3203
|
4.3
|
22.2
|
1.0
|
H3
|
A:XV3203
|
4.4
|
26.9
|
1.0
|
CG2
|
A:VAL9
|
4.4
|
17.9
|
1.0
|
O
|
A:HOH382
|
4.4
|
20.9
|
1.0
|
C10
|
A:XV3203
|
4.5
|
22.8
|
1.0
|
H5
|
A:XV3203
|
4.6
|
23.7
|
1.0
|
CG
|
A:TYR96
|
4.7
|
22.8
|
1.0
|
C2
|
A:XV3203
|
4.8
|
21.3
|
1.0
|
CA
|
A:VAL9
|
4.9
|
18.1
|
1.0
|
C3
|
A:XV3203
|
5.0
|
26.6
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 8un4
Go back to
Fluorine Binding Sites List in 8un4
Fluorine binding site 3 out
of 4 in the Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F203
b:21.1
occ:1.00
|
F2
|
A:XV3203
|
0.0
|
21.1
|
1.0
|
C6
|
A:XV3203
|
1.3
|
22.9
|
1.0
|
F
|
A:XV3203
|
2.1
|
22.6
|
1.0
|
F1
|
A:XV3203
|
2.1
|
21.7
|
1.0
|
C5
|
A:XV3203
|
2.4
|
21.3
|
1.0
|
H3
|
A:XV3203
|
2.5
|
26.9
|
1.0
|
H1
|
A:XV3203
|
2.6
|
26.9
|
1.0
|
C
|
A:XV3203
|
2.8
|
22.2
|
1.0
|
C1
|
A:XV3203
|
2.9
|
20.3
|
1.0
|
CG1
|
A:VAL9
|
3.4
|
19.4
|
1.0
|
CE
|
A:MET72
|
3.5
|
21.5
|
1.0
|
C4
|
A:XV3203
|
3.6
|
21.1
|
1.0
|
CG1
|
A:ILE100
|
3.6
|
21.3
|
1.0
|
H2
|
A:XV3203
|
3.9
|
26.9
|
1.0
|
CE2
|
A:PHE78
|
4.1
|
22.0
|
1.0
|
CD1
|
A:ILE100
|
4.2
|
20.5
|
1.0
|
C2
|
A:XV3203
|
4.2
|
21.3
|
1.0
|
C7
|
A:XV3203
|
4.2
|
21.4
|
1.0
|
CD2
|
A:PHE78
|
4.2
|
24.0
|
1.0
|
CB
|
A:VAL9
|
4.3
|
15.5
|
1.0
|
CL
|
A:XV3203
|
4.6
|
21.4
|
1.0
|
CG2
|
A:VAL9
|
4.7
|
17.9
|
1.0
|
N
|
A:XV3203
|
4.7
|
22.6
|
1.0
|
C8
|
A:XV3203
|
4.7
|
20.4
|
1.0
|
CB
|
A:MET72
|
4.9
|
20.0
|
1.0
|
CG
|
A:MET72
|
4.9
|
25.2
|
1.0
|
H4
|
A:XV3203
|
4.9
|
25.8
|
1.0
|
C3
|
A:XV3203
|
4.9
|
26.6
|
1.0
|
CB
|
A:ILE100
|
4.9
|
20.8
|
1.0
|
C12
|
A:XV3203
|
5.0
|
23.5
|
1.0
|
O
|
A:TYR96
|
5.0
|
21.4
|
1.0
|
SD
|
A:MET72
|
5.0
|
26.4
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 8un4
Go back to
Fluorine Binding Sites List in 8un4
Fluorine binding site 4 out
of 4 in the Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Kras-G13D-Gdp in Complex with CPD36 ((E)-1-((3S)-4-(7-(6-Amino-4- Methyl-3-(Trifluoromethyl)Pyridin-2-Yl)-6-Chloro-8-Fluoro-2-(((S)-2- Methylenetetrahydro-1H-Pyrrolizin-7A(5H)-Yl)Methoxy)Quinazolin-4-Yl)- 3-Methylpiperazin-1-Yl)-3-(4-((Dimethylamino)Methyl)-5-Methylpyridin- 2-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F203
b:24.8
occ:1.00
|
F3
|
A:XV3203
|
0.0
|
24.8
|
1.0
|
C12
|
A:XV3203
|
1.3
|
23.5
|
1.0
|
C7
|
A:XV3203
|
2.3
|
21.4
|
1.0
|
C11
|
A:XV3203
|
2.4
|
22.8
|
1.0
|
N1
|
A:XV3203
|
2.7
|
23.8
|
1.0
|
C4
|
A:XV3203
|
2.8
|
21.1
|
1.0
|
NE2
|
A:HIS95
|
3.1
|
24.1
|
1.0
|
OH
|
A:TYR64
|
3.3
|
30.9
|
1.0
|
C5
|
A:XV3203
|
3.3
|
21.3
|
1.0
|
N
|
A:XV3203
|
3.5
|
22.6
|
1.0
|
O
|
A:HOH316
|
3.6
|
43.0
|
1.0
|
F
|
A:XV3203
|
3.6
|
22.6
|
1.0
|
C8
|
A:XV3203
|
3.6
|
20.4
|
1.0
|
CG
|
A:GLN99
|
3.6
|
22.0
|
1.0
|
C10
|
A:XV3203
|
3.6
|
22.8
|
1.0
|
F1
|
A:XV3203
|
3.7
|
21.7
|
1.0
|
C6
|
A:XV3203
|
3.7
|
22.9
|
1.0
|
CE1
|
A:HIS95
|
3.8
|
24.6
|
1.0
|
CE1
|
A:TYR64
|
3.9
|
30.2
|
1.0
|
CB
|
A:GLN99
|
4.0
|
26.1
|
1.0
|
CD2
|
A:HIS95
|
4.0
|
23.4
|
1.0
|
C13
|
A:XV3203
|
4.0
|
23.6
|
1.0
|
CZ
|
A:TYR64
|
4.1
|
32.5
|
1.0
|
C9
|
A:XV3203
|
4.1
|
19.6
|
1.0
|
CE1
|
A:TYR96
|
4.3
|
21.0
|
1.0
|
CD1
|
A:TYR96
|
4.3
|
19.2
|
1.0
|
C1
|
A:XV3203
|
4.3
|
20.3
|
1.0
|
C3
|
A:XV3203
|
4.4
|
26.6
|
1.0
|
CD
|
A:GLN99
|
4.6
|
29.6
|
1.0
|
O1
|
A:XV3203
|
4.7
|
25.1
|
1.0
|
C2
|
A:XV3203
|
4.8
|
21.3
|
1.0
|
C14
|
A:XV3203
|
4.8
|
22.3
|
1.0
|
ND1
|
A:HIS95
|
4.8
|
26.0
|
1.0
|
N2
|
A:XV3203
|
4.9
|
22.5
|
1.0
|
OE1
|
A:GLN99
|
5.0
|
30.9
|
1.0
|
CB
|
A:GLU62
|
5.0
|
35.5
|
1.0
|
CG
|
A:HIS95
|
5.0
|
27.4
|
1.0
|
OE2
|
A:GLU62
|
5.0
|
34.2
|
1.0
|
|
Reference:
M.H.Ultsch,
C.Nilewski.
Structure-Based Design and Evaluation of Reversible Kras G13D Inhibitors To Be Published.
Page generated: Sat Aug 3 01:08:37 2024
|